Role of dexamethasone on vasopressin release during endotoxemic shock

被引:14
作者
Batalhao, M. E. [2 ]
Moreto, V. [2 ]
Stabile, A. M. [1 ]
Antunes-Rodrigues, J. [2 ]
Carnio, E. C. [1 ]
机构
[1] Univ Sao Paulo, Escola Enfermagem Ribeirao Preto, Dept Enfermagem Geral & Especializada, BR-14040902 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Fisiol, BR-14040902 Ribeirao Preto, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
endotoxemia; nitric oxide; endotoxin; blood pressure; glucocorticoids; lipopolisaccharide;
D O I
10.1016/j.regpep.2008.01.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study was designed to assess the hypothesis that dexamethasone (DEX) through the control of nitric oxide (NO) synthesis could regulate the release of vasopressin (AVP), which plays an important role in the regulation of arterial pressure and plasma osmolality. Endotoxemic shock was induced by intravenous (i.v.) injection of 1.5 mg/kg lipopolisaccharide (LPS) in male Wistar rats weighing 250-300 g. After LPS administration, a group of animals were treated with DEX (1.0 mg/kg of body weight), whereas saline-injected rats served as controls. The LPS administration induced a significant decrease in mean arterial pressure (MAP) with a concomitant increase in heart rate (HR) (Delta VMAP: -16.1 +/- 4.2 mm Hg; Delta VHR: 47.3 +/- 8.1 bpm). An increase in plasma AVP concentration occurred and was present for 2 h after LPS administration (11.1 +/- 0.9 pg/mL) returning close to basal levels thereafter and remaining unchanged until the end of the experiment. When LPS was combined with i.v. administration of a low dose of DEX, we observed an attenuation in the drop of MAP (Delta VMAP: -2.2 +/- 1.9 mm Hg) and a decrease in NO plasma concentration [NO] after LPS administration (1098.1 +/- 68.1 mu M) compared to [NO] after DEX administration (523.4 +/- 75.2 mu M). However, this attenuation in the drop of MAP was accompanied by a decrease in AVP plasma concentration (3.7 +/- 0.4 pg/mL). These data suggest that AVP does not participate in the recovery of MAP when DEX is administered in this endotoxemic shock model. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 34 条
[1]   The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock [J].
Altavilla, D ;
Squadrito, F ;
Campo, GM ;
Squadrito, G ;
Arlotta, M ;
Urna, G ;
Sardella, A ;
Quartarone, C ;
Saitta, A ;
Caputi, AP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 369 (01) :49-55
[2]  
Angus D, 2001, CRIT CARE MED, V29, P1472
[3]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[4]   A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: Comparison with two nonselective strategies [J].
Aranow, JS ;
Zhuang, J ;
Wang, HL ;
Larkin, V ;
Smith, M ;
Fink, MP .
SHOCK, 1996, 5 (02) :116-121
[5]   MEASUREMENT OF NITRIC-OXIDE IN BIOLOGICAL MODELS [J].
ARCHER, S .
FASEB JOURNAL, 1993, 7 (02) :349-360
[6]  
BAUMGARTNER JD, 1995, DRUGS, V7, P127
[7]   Effect of hydrocortisone on phenylephrine-mean arterial pressure dose-response relationship in septic shock [J].
Bellissant, E ;
Annane, D .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (03) :293-303
[8]   Reversal of late septic shock with supraphysiologic doses of hydrocortisone [J].
Bollaert, PE ;
Charpentier, C ;
Levy, B ;
Debouverie, M ;
Audibert, G ;
Larcan, A .
CRITICAL CARE MEDICINE, 1998, 26 (04) :645-650
[9]   A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK [J].
BONE, RC ;
FISHER, CJ ;
CLEMMER, TP ;
SLOTMAN, GJ ;
METZ, CA ;
BALK, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) :653-658
[10]   Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study [J].
Briegel, J ;
Forst, H ;
Haller, M ;
Schelling, G ;
Kilger, E ;
Kuprat, G ;
Hemmer, B ;
Hummel, T ;
Lenhart, A ;
Heyduck, M ;
Stoll, C ;
Peter, K .
CRITICAL CARE MEDICINE, 1999, 27 (04) :723-732